Dancann Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Dancann Pharma has a total shareholder equity of DKK60.5M and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK64.6M and DKK4.1M respectively.
Key information
0%
Debt to equity ratio
DKK 0
Debt
| Interest coverage ratio | n/a |
| Cash | DKK 2.01m |
| Equity | DKK 60.48m |
| Total liabilities | DKK 4.14m |
| Total assets | DKK 64.61m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DCPX.F's short term assets (DKK4.7M) exceed its short term liabilities (DKK4.1M).
Long Term Liabilities: DCPX.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DCPX.F is debt free.
Reducing Debt: DCPX.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DCPX.F has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: DCPX.F is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.